Detalles de la búsqueda
1.
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 159(1): 79-87, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32723679
2.
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
N Engl J Med
; 374(8): 738-48, 2016 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26933849
3.
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 149(3): 525-530, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550184
4.
Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer.
J Obstet Gynaecol
; 38(3): 395-401, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29385863
5.
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(6): 779-791, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28438473
6.
Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers.
Psychooncology
; 26(11): 1799-1809, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27421919
7.
The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.
Gynecol Oncol
; 141(3): 434-439, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27090796
8.
Correlation of pelvic magnetic resonance imaging diagnosis with pathology for indeterminate adnexal masses.
Int J Gynecol Cancer
; 24(7): 1215-21, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25153677
9.
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.
Cancer Immunol Immunother
; 61(5): 629-41, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22021066
10.
A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study.
Gynecol Oncol
; 127(2): 356-61, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22796461
11.
Clinical predictors of bevacizumab-associated gastrointestinal perforation.
Gynecol Oncol
; 120(3): 464-9, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21168199
12.
Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity.
Gynecol Oncol
; 120(1): 108-12, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20937524
13.
A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.
Gynecol Oncol
; 121(2): 264-8, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21277623
14.
Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: a gynecologic oncology group study.
Gynecol Oncol
; 123(2): 182-6, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21820161
15.
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.
Gynecol Oncol
; 123(1): 19-26, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21752435
16.
A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer.
Gynecol Oncol
; 123(3): 486-91, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21945552
17.
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
Gynecol Oncol
; 115(2): 215-20, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19712963
18.
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
J Clin Oncol
; 37(16): 1380-1390, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002578
19.
Secondary surgical cytoreduction for advanced ovarian carcinoma.
N Engl J Med
; 351(24): 2489-97, 2004 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-15590951
20.
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
N Engl J Med
; 348(3): 203-13, 2003 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-12529460